FDA approves Lannett’s Generic Neomycin Sulfate Tablets

FDA approval#1

The FDA has approved Lannett’s Abbreviated New Drug Application for Neomycin Sulfate Tablets USP in the 500 mg dosage. Teva Pharmaceuticals USA produces the branded version of the drug. According to IMS Health data, total 2015 US sales at Average Wholesale Price were about $3 million. Lannett has said the drug will expand its antibiotic and anti-infective portfolio.

Read the source article at Pharmacy Choice

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>